GenVault Biorepository Announces Executive Director Appointment

WEST DEPTFORD, N.J.--(BUSINESS WIRE)-- GenVault, one of the nation’s most secure, comprehensive commercial facilities for bioinventory storage and transport, announces the appointment of Andrew Lee as executive director. A veteran of the U.S. Air Force, Lee has more than 16 years of experience in pathology, oncology, clinical trials research development, and project management. Prior to joining GenVault, Lee held leadership roles in biorepository and research informatics at Encoded Therapeutics (focused on transformative gene therapy), and in BMP Biorepository and Molecular Pathology at the Huntsman Cancer Institute. Lee holds both a Bachelor of Science in Biology and a Master of Healthcare Administration from the University of Utah.

“We are excited to have Andrew join our team at GenVault. His extensive life science experience, coupled with operations management expertise, will continue to advance the unparalleled services we provide for our clients,” said GenVault president and CEO Keith DiMarino.

GenVault is one of the nation’s most secure, comprehensive commercial biorepositories. Located in West Deptford, NJ, it shares a half-million square foot purpose-built campus with its sister facility DocuVault, which opened in 2002 as the region’s only facility specifically designed and built for records management. GenVault serves stores and transport large collections of biological materials, laboratory chemicals, infectious and non-infectious materials, and high-value equipment for academic research institutes, pharma companies, biotech, and government.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230809679282/en/

Laura Feragen
Jacobson Strategic Communications
[email protected]
267-262-4309

Source: GenVault

You May Also Be Interested In

• DELETED: Reliable Robotics Completes Autonomous Cross-Country Flight
• Hubble Network Brings Global Bluetooth Connectivity to Edge AI Designs in Renesas 365
• Legrand: Total Number of Shares and Voting Rights